11
Hyperphosphatemia in Children With Chronic Kidney Disease
Condition(s):HyperphosphatemiaLast Updated:June 28, 2017Unknown status
Eliphos: 29 Clinical Trials, Page 2 of 3
Hide Studies Not Open or Pending
12
Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat
Condition(s):Healthy VolunteersLast Updated:October 8, 2020Completed
13
Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)
Condition(s):We Investigated the Relationship Between Plasma FGF23 Levels and Endothelial Dysfunction in a Sizable Series of Incident Stage 3-4 CKD Patients.Last Updated:July 22, 2011Completed
14
Phosphate Kinetic Modeling 2
Condition(s):Hyperphosphatemia; ESRDLast Updated:August 18, 2014Completed
15
Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion.
Condition(s):Healthy; Chronic Kidney DiseasesLast Updated:February 6, 2017Completed
16
A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD
Condition(s):Chronic Kidney DiseaseLast Updated:October 30, 2012Completed
17
Occlusion vs Standard Treatment for the Treatment of Herpes Zoster
Condition(s):Herpes ZosterLast Updated:February 28, 2020Unknown status
18
Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD
Condition(s):Vascular DiseasesLast Updated:June 19, 2007Completed
19
Phosphate Kinetic Modeling
Condition(s):End Stage Renal Disease; HyperphosphatemiaLast Updated:August 18, 2014Completed
20
Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V
Condition(s):CKD Stage 5Last Updated:January 23, 2023Active, not recruiting